Community-based amoxicillin treatment for fast breathing pneumonia in young infants 7-59 days old: A cluster randomised trial in rural Bangladesh, Ethiopia, India and Malawi

Young infants 7–59 days old with fast breathing pneumonia presented to a primary level health facility receive a 7-day course of amoxicillin as per the WHO guideline. However, community-level health workers (CLHW) are not allowed to treat these infants. This trial evaluated the community level treatment of non-hypoxaemic young infants with fast breathing pneumonia by CLHWs.